NCT01165554View on ClinicalTrials.gov

Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels

PHASE3CompletedINTERVENTIONAL
Enrollment

203

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Brain Fibrillarab Levels
Interventions
DRUG

[18F] Flutemetamol

Flutemetamol (18F) Injection, 111 to 370 MBq (3 to 10 mCi), single intravenous injection.

Trial Locations (1)

08540

GE Healthcare, Princeton

Sponsors

Lead Sponsor

GE Healthcare

Collaborators (1)

Covance
All Listed Sponsors
collaborator

i3 Statprobe

INDUSTRY

collaborator

Covance

INDUSTRY

lead

GE Healthcare

INDUSTRY